Cure Today1h
SBRT May Be Superior to Radiofrequency Ablation in Liver Cancer
SBRT improved local progression-free survival over RFA in small recurrent HCC, particularly in tumors 2 cm or less.
News Medical on MSN9h
Novel therapeutic approaches targeting the Wnt pathway in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates.
Treating liver fibrosis and metabolic dysfunction-associated steatohepatitis: Research identifies novel mechanism
Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...
EurekAlert!1d
Unraveling the role of the Wnt pathway in hepatocellular carcinoma: From molecular mechanisms to therapeutic implications
Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors in the world, and its incidence and mortality have ...
Eating veggies may reduce risk of liver cancer by 65 per cent, finds study
Liver cancer is the sixth most frequent cancer worldwide, mainly represented by hepatocellular carcinoma, accounting for ...
Liver Cancer Therapeutics Market to Hit USD 15.69 Billion by 2032, growing at a CAGR of 19.21% - SNS Insider
Liver Cancer Therapeutics Market Growth is Driven by Advancements in Precision Medicine, Immunotherapy and Growing Global Incidence.Pune, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Liver Cancer Therapeutics ...
Liver Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
Promising Liver Cancer Therapies such as Atezolizumab, Bevacizumab, Tiragolumab, OH2 injection, MTL-CEBPA, Sorafenib 200mg, ...
Armed robbery in Revesby1d
FGF21 Triggers PPP6C for Liver Fibrosis Treatment
Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...
Eating carrots, cauliflowers may reduce risk of liver cancer by 65 pc: Study
INSERM's latest study finds eating over 240g of vegetables daily cuts liver cancer risk by 65% in cirrhosis patients.
Taiwan News7d
Lion TCR's Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular Carcinoma
On 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has ...
manilatimes9d
Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma
BRISBANE, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology ...